Expanding anti-CD38 immunotherapy for lymphoid malignancies

BACKGROUND: Lymphoid neoplasms, including multiple myeloma (MM), non-Hodgkin lymphoma (NHL), and NK/T cell neoplasms, are a major cause of blood cancer morbidity and mortality. CD38 (cyclic ADP ribose hydrolase) is a transmembrane glycoprotein expressed on the surface of plasma cells and MM cells. T...

Descripción completa

Detalles Bibliográficos
Autores principales: Wang, Xu, Yu, Xinfang, Li, Wei, Neeli, Praveen, Liu, Ming, Li, Ling, Zhang, Mingzhi, Fang, Xiaosheng, Young, Ken H., Li, Yong
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2022
Materias:
Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9237984/
https://www.ncbi.nlm.nih.gov/pubmed/35765110
http://dx.doi.org/10.1186/s13046-022-02421-2

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9237984/
https://www.ncbi.nlm.nih.gov/pubmed/35765110
http://dx.doi.org/10.1186/s13046-022-02421-2

Ejemplares similares